1. Introduction
===============

Recently, we published the results of a cross-sectional polysomnographic (PSG) study in consecutive multiple sclerosis (MS) patients \[[@B1-ijms-16-16514]\]. Of 66 patients who underwent PSG, 49 suffered from a sleep disorder (SD); seven of these suffered from more than one SD. In these cases we classified only the more severe SD. In our study, SDs were significantly related to fatigue; and a follow-up investigation showed that a consequent treatment of sleep disorders may improve fatigue in a subset of patients \[[@B2-ijms-16-16514]\]. The improvement of MS fatigue after medical treatment of SD was seen in another follow up study as well \[[@B3-ijms-16-16514]\]. With regards to the relationship between health related Quality of Life (HRQoL) and SD in MS patients, there are only a few studies: Neau *et al.* \[[@B4-ijms-16-16514]\], as well as Sarraf *et al.* \[[@B5-ijms-16-16514]\], classified MS patients into good sleepers and poor sleepers using the Pittsburgh Sleep Quality Index \[[@B6-ijms-16-16514]\] (PSQI) (PSQI ≤ 5 *vs.* \> 5). In their studies, poor sleepers showed a reduced HRQoL using the MS-QOL-54 \[[@B7-ijms-16-16514]\]. To our knowledge, there is only one study investigating the relationship between SDs confirmed by PSG and HRQoL in MS: Trojan *et al.* demonstrated a decreased mental but not physical HRQoL in MS patients with SD \[[@B8-ijms-16-16514]\] using the Short Form Health Survey (SF-36) \[[@B9-ijms-16-16514]\].

To date, there is no study investigating the HRQoL in MS patients with the Nottingham Health Profile (NHP) \[[@B10-ijms-16-16514]\]. The NHP is a valid and reliable indicator of subjective health status in physical, social and emotional areas \[[@B10-ijms-16-16514]\]. The NHP consists of two parts (part 1 and 2). Only part 1 is weighted and is composed of six subscales (*sleep*, *physical mobility*, *energy*, *pain*, *emotional reactions* and *social isolation*); the maximum of any subscale is 100. As a result, the maximum of the NHP total score is 600 (the higher the NHP values, the lower the HRQoL). The weighting of the 38 statements reflects the symptom severity and represents rather severe problems in order to avoid picking up a large number of false positives \[[@B10-ijms-16-16514]\]. In the literature mine rescue workers show a very low global mean NHP score of 8.8; fit elderly persons show a mean global NHP score of 12.4; whereas pregnant women at 37 weeks, fracture victims and chronically ill elderly patients (mean global NHP 127.0/129.6/156.4) show increased NHP values, and especially high values were obtained in patients with osteoarthrosis (mean global NHP 271.3) \[[@B10-ijms-16-16514]\]. Verwimp *et al.* investigated 75 OSA patients \[[@B11-ijms-16-16514]\] and found an increased global NHP median (218). In their study the negative perception in the "physical abilities" domain was effectively related to an objective low level of physical activity measured by actigraphy.

In our previous cross-sectional trial we also collected NHP data, which had not been analysed and published before. The aim of this study is to describe these data and to investigate the relationship between SD and HRQoL in MS.

2. Results
==========

2.1. Patients
-------------

We classified the 66 patients (21 men and 45 women aged 20--66 years) into four subgroups: no sleep disorder (NSD) (*n* = 17), insomnia (*n* = 17) (INS), periodic limb movement disorder (PLMD), restless legs syndrome (RLS) or SD due to leg pain (PLMD/RLS) (*n* = 24), and untreated obstructive sleep apnea (OSA) (*n* = 8). Expanded Disability Status Scale (EDSS) \[[@B12-ijms-16-16514]\] values ranged from zero to eight.

### 2.1.1. HRQoL in MS Patients with Sleep Disorders Compared to Patients without Sleep Disorders

[Table 1](#ijms-16-16514-t001){ref-type="table"} shows the NHP values in patients without SD compared with those patients suffering from SD (all SD together). MS patients suffering from SD showed significantly increased NHP values, indicating poorer HRQoL using the Mann--Whitney-*U*-test.

ijms-16-16514-t001_Table 1

###### 

NHP values in patients with and without sleep disorders.

  NHP Global Score and Subscales   Average and Range            All Patients     Patients without Sleep Disorders   Patients with Sleep Disorders   Differences between the Two Subgroups
  -------------------------------- ---------------------------- ---------------- ---------------------------------- ------------------------------- ---------------------------------------
  NHP-Total                        Mean (±standard deviation)   146.1 (±119.8)   67.3 (±60.0)                       175.2 (±123.6)                  *p* = 0.001
  Min--Max                         0.0--78.7                    0.0--188.6       0.0--413.7                                                         
  25--75                           0.0--32.6                    21.8--120.5      61.3--273.3                                                        
  median                           126.4                        34.8             175.5                                                              
  Physical abilities               Mean (±standard deviation)   20.9 (±21.5)     10.2 (±14.7)                       24.8 (±22.4)                    *p* = 0.010
  Min--Max                         0.0--78.7                    0.0--54.5        0.0--78.7                                                          
  25--75                           0.0--32.6                    0.0--22.0        10.8--36.5                                                         
  median                           12.7                         0.0              21.7                                                               
  Social isolation                 Mean (±standard deviation)   11.7 (±19.6)     3.6 (±8.0)                         14.7 (±21.8)                    *p* = 0.048
  Min--Max                         0.0--80.6                    0.0--22.5        0.0--80.6                                                          
  25--75                           0.0--20.1                    0.0--0.0         0.0--22.5                                                          
  median                           0.0                          0.0              0.0                                                                
  Sleep                            Mean (±standard deviation)   29.3 (±29.5)     10.6 (±15.1)                       36.2 (±30.6)                    *p* = 0.001
  Min--Max                         0.0--100.0                   0.0--50.4        0.0--100.0                                                         
  25--75                           0.0--16.1                    0.0--12.6        12.6--72.7                                                         
  median                           50.4                         0.0              28.7                                                               
  Pain                             Mean (±standard deviation)   15.8 (±24.8)     3.8 (±9.8)                         20.2 (±27.2)                    *p* = 0.009
  Min--Max                         0.0--100.0                   0.0--32.3        0.0--100.0                                                         
  25--75                           0.0--0.0                     0.0--0.0         0.0--30.6                                                          
  median                           26.0                         0.0              9.9                                                                
  Energy                           Mean (±standard deviation)   48.9 (±40.9)     29.9 (±35.5)                       55.8 (±40.9)                    *p* = 0.016
  Min--Max                         0.0--100.0                   0.0--100.0       0.0--100.0                                                         
  25--75                           0.0--60.8                    0.0--62.0        24.0--100.0                                                        
  median                           100.0                        0.0              62.0                                                               
  Emotional                        Mean (±standard deviation)   19.6 (±18.8)     9.3 (±12.2)                        23.5 (±19.5)                    *p* = 0.006
  Min--Max                         0.0--69.0                    0.0--41.4        0.0--69.0                                                          
  25--75                           0.0--30.9                    0.0--18.6        5.3--41.4                                                          
  median                           16.8                         0.0              21.0                                                               

### 2.1.2. Comparison of the Global NHP Values (Global HRQoL) in the Four Subgroups

The comparison of the global NHP (including all six subscales) in the four subgroups showed significantly lower NHP values in the NSD and PLMD/RLS patients compared to OSA and insomnia patients; whereas there were no significant differences between NSD and PLMD/RLS patients neither between OSA and insomnia patients (see [Figure 1](#ijms-16-16514-f001){ref-type="fig"} and [Table 2](#ijms-16-16514-t002){ref-type="table"}). This suggests that NSD and PLMD/RLS patients have a better global HRQoL compared to OSA or insomnia patients.

![Nottingham Health Profile total values in the four subgroups.](ijms-16-16514-g001){#ijms-16-16514-f001}
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###### 

NHP total score and NHP items in the different subgroups.

  ---------------------------------------------------------------------------------------------------------------------------------------------------
  NHP Values           Average and Range   All Patients   NSD            INS            OSA           PLM     Differences between the Two Subgroups
  -------------------- ------------------- -------------- -------------- -------------- ------------- ------- ---------------------------------------
  Total                Mean (SD)           146.1          67.3           220.3          239.6         119.9   NSD *vs.* OSA\
                                                                                                              *p* = 0.003\
                                                                                                              NSD *vs.* INS\
                                                                                                              *p* \< 0.0001\
                                                                                                              INS *vs.* PLM\
                                                                                                              *p* = 0.002\
                                                                                                              OSA *vs.* PLM\
                                                                                                              *p* = 0.042\
                                                                                                              NSD *vs.* PLM\
                                                                                                              *p* = 0.210\
                                                                                                              OSA *vs.* INS\
                                                                                                              *p* = 0.804

  Standard deviation   119.8               60.0           88.2           136.2          123.7                 

  Min--Max             0.0--78.7           0.0--188.6     60.7--369.9    24.7--413.7    0.0--408.61           

  25--75               0.0--32.6           21.8--120.5    147.0--276.0   180.8--393.3   29.7--174.4           

  Median               126.4               34.8           212.3          194.9          75.8                  
  ---------------------------------------------------------------------------------------------------------------------------------------------------

### 2.1.3. Comparison of the NHP Subscales in the Four Subgroups

[Figure 2](#ijms-16-16514-f002){ref-type="fig"} displays the NHP values in the different subgroups. The patients without sleep disorders showed the lowest NHP values in all items. The insomnia subgroup showed the highest values in the "*sleep*" item. Attention should also be paid to the high values concerning "*energy*" (and to a lower extent regarding "*emotions*") in the insomnia and OSA subgroup. Please take into account the high values regarding "*physical abilities*" in the OSA subgroup.

![Subscales of the NHP in the different sleep disorders (mean values).](ijms-16-16514-g002){#ijms-16-16514-f002}

### Kruskal--Wallis-Test

We performed the non-parametric Kruskal--Wallis-Test for comparing the four subgroups with different sample sizes. The Kruskal--Wallis-Test showed significant differences between the four subgroups for all items except for "*social isolation*", meaning that this item seemed not to be different in the four subgroups---therefore, this item was not included in the further analysis (see [Table 3](#ijms-16-16514-t003){ref-type="table"}).
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###### 

Kruskal--Wallis-Test.

  NHP Total       Physical Abilities   Social Isolation   Sleep         Pain          Energy          Emotional
  --------------- -------------------- ------------------ ------------- ------------- --------------- ---------------
  *p* \< 0.0001   *p* = 0.007          *p* = 0.054        *p* = 0.001   *p* = 0.034   *p* \< 0.0001   *p* \< 0.0001

### Mann--Whitney-*U*-Test

We subsequently analysed the NHP subscales (except for "*social isolation*"): a Mann--Whitney-*U*-test was performed in order to analyse the differences between two specific subgroups (OSA--PLM/OSA--INS/OSA--NSD/PLM--INS/PLM--NSD/INS--NSD). Five items (*physical abilities*, *sleep*, *pain*, *energy*, *emotional*) remained in the further analysis (see [Table 3](#ijms-16-16514-t003){ref-type="table"}).

In four subscales (*physical abilities*, *sleep*, *energy*, *emotional*) we found significantly lower NHP values in NSD patients compared to insomnia and OSA patients (in the *pain* area there was only a significant difference between NSD patients and insomnia patients---but not between NSD patients and OSA patients) (see [Table 4](#ijms-16-16514-t004){ref-type="table"}). This means that the HRQoL in these specific areas was higher in MS patients without comorbid sleep disorders compared to MS patients suffering from comorbid OSA or insomnia.
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###### 

NHP subscale values in all patients and in the four subgroups.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Subscales            Average and Range           All Patients   NSD           INS           OSA           PLM           Differences between the Two Subgroups
  -------------------- --------------------------- -------------- ------------- ------------- ------------- ------------- ------------------------------------------------------------
  Physical abilities   Mean (Standard deviation)   20.9 (21.5)    10.2 (14.7)   27.4 (20.8)   41.0 (24.3)   17.7 (20.8)   NSD *vs.* OSA *p* = 0.003\
                                                                                                                          NSD *vs.* INS *p =* 0.009\
                                                                                                                          INS *vs.* PLM *p* = 0.138\
                                                                                                                          OSA *vs.* PLM *p =* 0.032\
                                                                                                                          NSD *vs.* PLM *p =* 0.211\
                                                                                                                          OSA *vs.* INS *p =* 0.260

  Min--Max             0.0--78.7                   0.0--54.5      0.0--77.3     10.8--78.2    0.0--78.7                   

  25--75               0.0--32.6                   0.0--21.9      10.8--42.6    21.7--67.2    0.0--25.8                   

  Median               12.7                        0.0            22.0          32.6          11.2                        

  Social isolation     Mean (Standard deviation)   11.7 (19.6)    3.6 (8.0)     12.8 (19.0)   29.5 (31.0)   11.6 (19.4)   For this subgroup no Mann--Whitney-*U*-Test was performed\
                                                                                                                          (see [Table 2](#ijms-16-16514-t002){ref-type="table"})

  Min--Max             0.0--80.6                   0.0--22.5      0.0--64.7     0.0--80.6     0.0--63.9                   

  25--75               0.0--20.1                   0.0--0.0       0.0--22.5     0.0--63.9     0.0--20.2                   

  Median               0.0                         0.0            0.0           20.1          0.0                         

  Sleep                Mean (Standard deviation)   29.3 (29.5)    10.6 (15.2)   48.7 (26.7)   26.8 (27.4)   29.5 (32.4)   NSD *vs.* OSA *p =* 0.087\
                                                                                                                          NSD *vs.* INS *p* \< 0.0001\
                                                                                                                          INS *vs.* PLM *p* = 0.048\
                                                                                                                          OSA *vs.* PLM *p* = 0.980\
                                                                                                                          NSD *vs.* PLM *p* = 0.063\
                                                                                                                          OSA *vs.* INS *p* = 0.075

  Min--Max             0.0--100.0                  0.0--50.4      0.0--77.6     0.0--77.6     0.0--100                    

  25--75               0.0--16.1                   0.0--12.6      25.2--75.2    12.6--50.4    0.0--50.4                   

  Median               50.4                        0.0            50.4          12.6          14.3                        

  Pain                 Mean (Standard deviation)   15.8 (24.8)    3.8 (9.8)     21.9 (23.9)   27.0 (31.4)   16.6 (28.9)   NSD *vs.* OSA *p* = 0.114\
                                                                                                                          NSD *vs.* INS *p =* 0.012\
                                                                                                                          INS *vs.* PLM *p* = 0.221\
                                                                                                                          OSA *vs.* PLM *p* = 0.469\
                                                                                                                          NSD *vs.* PLM *p =* 0.117\
                                                                                                                          OSA *vs.* INS *p =* 0.804

  Min--Max             0.0--100.0                  0.0--32.7      0.0--69.8     0.0--80.2     0.0--100.0                  

  25--75               0.0--0.0                    0.0--0.0       0.0--40.1     0.0--56.9     0.0--18.6                   

  Median               26.0                        0.0            15.8          26.0          0.0                         

  Energy               Mean (Standard deviation)   48.9 (40.9)    29.9 (35.5)   78.5 (28.7)   80.5 (38.0)   30.5 (35.4)   NSD *vs.* OSA *p* = 0.007\
                                                                                                                          NSD *vs.* INS *p* \< 0.0001\
                                                                                                                          INS *vs.* PLM *p* \< 0.0001\
                                                                                                                          OSA *vs.* PLM *p* = 0.013\
                                                                                                                          NSD *vs.* PLM *p* = 0.790\
                                                                                                                          OSA *vs.* INS *p* = 0.710

  Min--Max             0.0--100.0                  0.0--100.0     24.0--100.0   0.0--100.0    0.0--100.0                  

  25--75               0.0--60.8                   0.0--62.0      60.8--100.0   63.2--100.0   0.0--61.4                   

  Median               100.0                       0.0            100.0         100.0         24.0                        

  Emotional            Mean (Standard deviation)   19.6 (18.8)    9.3 (12.2)    30.9 (19.8)   34.8 (16.8)   14.1 (15.9)   NSD *vs.* OSA *p* = 0.001\
                                                                                                                          NSD *vs.* INS *p* = 0.001\
                                                                                                                          INS *vs.* PLM *p* = 0.007\
                                                                                                                          OSA *vs.* PLM *p* = 0.008\
                                                                                                                          NSD *vs.* PLM *p* = 0.392\
                                                                                                                          OSA *vs.* INS *p* = 0.619

  Min--Max             0.0--69.0                   0.0--41.4      0.0--69.0     13.6--55.9    0.0--48.5                   

  25--75               0.0--30.9                   0.0--18.6      14.1--47.1    17.0--52.0    0.0--22.7                   

  Median               16.8                        0.0            30.9          30.9          10.9                        
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

In sum, the differences between the OSA and insomnia subgroups were very small and not significant. Similarly, the differences between NSD and the PLMD/RLS patients were negligible. Significant clinical relevant differences were found comparing NSD and the PLMD/RLS patients to OSA and insomnia patients.

The comparison between PLMD/RLS patients and insomnia patients showed significantly increased NHP values in the "sleep" subscale and highly significant increased NHP values in the "*energy*" and "*emotional*" subscale. That means that insomnia patients showed a reduced HRQoL in these areas compared to PLMD/RLS patients.

When comparing PLMD/RLS patients with OSA patients, there were significantly higher NHP values in OSA patients (decreased HRQoL) in the "*physical abilities*", "*energy*" and "*emotional*" subscales.

### 2.1.4. Comparison of the Objective (PSG) Sleep Parameters and the NHP Sleep Items

The sleep subscales consist of five items: "I sleep badly at night", "I lie awake for most of the night", "It takes me a long time to get to sleep", "I'm waking up in the early hours of the morning", "I take pills to help me sleep". Except for the last item ("I take pills to help me sleep"), we compared the other four items with PSG parameters using the Mann--Whitney-*U*-test: [Table 5](#ijms-16-16514-t005){ref-type="table"} shows the results:
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###### 

Comparison of polysomnographic data and NHP sleep items.

  Items                                                       Average and Range            Sleep Efficiency   Awakenings     Arousal-Index   Sleep Latency   Wake after Sleep Onset
  ----------------------------------------------------------- ---------------------------- ------------------ -------------- --------------- --------------- ------------------------
  I sleep badly at night ***YES***                            Mean (±standard deviation)   73.6 (±12.6)       25.5 (±7.7)    18.5 (±9.6)                     
  Min--Max                                                    50--94                       9--41              3.9--43.9                                      
  25--75                                                      63.7--83.5                   20--30.5           12.2--22.9                                     
  median                                                      74.8                         26.0               16.5                                           
  I sleep badly at night ***NO***                             Mean (±standard deviation)   76.7 (±16.2)       27.5 (±14.2)   20.5 (±10.0)                    
  Min--Max                                                    8--93                        8--72              1.1--47.1                                      
  25--75                                                      73.0--87.1                   17.8--33.3         14.4--24.9                                     
  median                                                      80.45                        26.0               21.7                                           
  Differences between ***YES*** and ***NO***                  *p* = 0.148                  *p* = 0.860        *p* = 0.255                                    
  I lie awake for most of the night ***YES***                 Mean (±standard deviation)   76.2 (±15.0)                                                      
  Min--Max                                                    8--93                                                                                          
  25--75                                                      69.8--87.0                                                                                     
  median                                                      79.7                                                                                           
  I lie awake for most of the night ***NO***                  Mean (±standard deviation)   71.1 (±13.5)                                                      
  Min--Max                                                    50--94                                                                                         
  25--75                                                      60.0--80.7                                                                                     
  median                                                      69.6                                                                                           
  Differences between ***YES*** and ***NO***                  *p* = 0.175                                                                                    
  It takes me a long time to get to sleep ***YES***           Mean (±standard deviation)                                                     38.5 (±39.8)    
  Min--Max                                                                                                                   2--198                          
  25--75                                                                                                                     15.3--49.5                      
  median                                                                                                                     29.0                            
  It takes me a long time to get to sleep ***NO***            Mean (±standard deviation)                                                     26.4 (±31.1)    
  Min--Max                                                                                                                   0--190                          
  25--75                                                                                                                     11.0--32.0                      
  median                                                                                                                     21.0                            
  Differences between ***YES*** and ***NO***                                                                                 *p* = 0.08                      
  I'm waking up in the early hours of the morning ***YES***   Mean (±standard deviation)                                                                     88.4 (±59.0)
  Min--Max                                                                                                                                   27--258         
  25--75                                                                                                                                     43.0--73.0      
  median                                                                                                                                     73.0            
  I'm waking up in the early hours of the morning ***NO***    Mean (±standard deviation)                                                                     69.8 (±41.4)
  Min--Max                                                                                                                                   20--173         
  25--75                                                                                                                                     43.3--88.8      
  median                                                                                                                                     52.5            
  Differences between ***YES*** and ***NO***                                                                                                 *p* = 0.336     

When we compared "*It takes me a long time to get to sleep*" to the sleep latency measured by PSG, there was no significant correlation between this subjective (NHP) and objective (PSG) measurement of sleep latency. Furthermore, we did not find any correlation between "*I sleep badly at night*" and sleep efficiency measured by PSG. Similarly the item "*I'm waking up in the early hours of the morning*" did not correlate with wake-after-sleep-onset in the PSG nor arousal-index or awakenings.

2.2. Correlation between NHP Values and Other Questionnaires
------------------------------------------------------------

[Table 6](#ijms-16-16514-t006){ref-type="table"} shows the non-parametric correlations (Spearman--Rho) between NHP and other self-assessed questionnaires (Modified Fatigue Impact Scale (MFIS) \[[@B13-ijms-16-16514]\]; Beck Depression Inventory (BDI) \[[@B14-ijms-16-16514]\]; Pittsburgh Sleep Quality Index (PSQI) \[[@B6-ijms-16-16514]\]).
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###### 

Non parametric correlations (Spearman-Rho) between NHP and other questionnaires (Beck Depression Inventory and Pittsburgh Sleep Quality Index).

  NHP and MFIS    NHP and BDI     NHP and PSQI
  --------------- --------------- ---------------
  *p* \< 0.0001   *p* \< 0.0001   *p* \< 0.0001
  *r* = 0.737     *r* = 0.836     *r* = 0.612

The scatter plots visualize these findings. There was a significant correlation between NHP values and MFIS values---meaning that higher fatigue values are associated with reduced HRQoL ([Figure 3](#ijms-16-16514-f003){ref-type="fig"}). In addition, higher NHP values (reduced HRQoL) were also associated with higher depression values (BDI, [Figure 4](#ijms-16-16514-f004){ref-type="fig"}) and higher PSQI values (low sleep quality, [Figure 5](#ijms-16-16514-f005){ref-type="fig"}). This indicates that reduced HRQoL is associated with depression, fatigue, and bad sleep quality.

![Correlation between NHP and MFIS values. Abbreviations: NHP = Nottingham Health Profile; MFIS = Modified Fatigue Impact Scale \[[@B13-ijms-16-16514]\].](ijms-16-16514-g003){#ijms-16-16514-f003}

![Correlation between NHP and BDI values. Abbreviations: NHP = Nottingham Health Profile; BDI = Beck Depression Inventory \[[@B14-ijms-16-16514]\].](ijms-16-16514-g004){#ijms-16-16514-f004}

![Correlation between NHP and PSQI values. Abbreviations: NHP = Nottingham Health Profile; PSQI = Pittsburgh Sleep Quality Index \[[@B6-ijms-16-16514]\].](ijms-16-16514-g005){#ijms-16-16514-f005}

### Correlation between NHP Values and the MFIS Subscales

Furthermore, we investigated the correlation between the NHP global score and the three subscales of the MFIS (cognition, psychosocial and physical): a significant correlation was found between the global HRQoL (NHP values) and psychosocial aspects of fatigue, as well cognitive fatigue and physical fatigue (see [Table 7](#ijms-16-16514-t007){ref-type="table"}):
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###### 

Non-parametric correlations (Spearman--Rho) between NHP and the fatigue subscales.

  NHP and Cognitive MFIS-Subscale   NHP and Physical MFIS-Subscale   NHP and Psychosocial MFIS-Subscale
  --------------------------------- -------------------------------- ------------------------------------
  *p* \< 0.0001                     *p* \< 0.0001                    *p* \< 0.0001
  *r* = 0.635                       *r* = 0.726                      *r* = 0.548

Abbreviations: NHP = Nottingham Health Profile; MFIS = Modified Fatigue Impact Scale.

3. Discussion
=============

Our study demonstrates poor HRQoL in MS patients suffering from sleep disorders confirmed by PSG---especially from OSA and insomnia. The global NHP median was marginally lower in MS patients suffering from OSA (194.9) compared with OSA patients in the general population (218.0) \[[@B11-ijms-16-16514]\]. Increased NHP values indicate severe health problems, and the mean global NHP score in MS patients with comorbid insomnia or OSA was higher than the mean scores described in the literature in pregnant women at 37 weeks, fracture victims and chronically ill elderly patients and almost as high as in patients with osteoarthrosis, whereas MS patients without sleep disorders show only moderately increased NHP values. OSA and insomnia can significantly reduce HRQoL in MS patients. MS patients suffering from PLMD, RLS or sleep disorders due to leg pain show a decreased HRQoL as well---although to a lesser extent.

The impairment of HRQoL in OSA and insomnia patients (besides the sleep problems) was more pronounced in the "*energy*" and "*emotional*" area. OSA patients are severely affected in the "*physical abilities*" as well (as described previously by Verwimp *et al.* in OSA patients without MS \[[@B11-ijms-16-16514]\]).

We cannot explain the lack of a correlation between the (objective) PSG parameter and the (subjective) sleep problems measured in the sleep subscale. This could be due to the fact that we investigated this relationship in different SDs (OSA, insomnia, PLMD/RLS).

The decreased HRQoL in OSA and insomnia patients in the "*energy*" and "*emotional*" area argue for consecutive daytime symptoms due to the sleep disorders (and "*physical abilities*" in OSA patients as well). Here, it is difficult to explain what exactly drives these daytime symptoms. As recently reported \[[@B15-ijms-16-16514]\], there is an overlap between fatigue, pain, depression, and sleep disorders. Moreover, OSA can lead to depression and continuous positive airway (CPAP) therapy can improve depression \[[@B16-ijms-16-16514]\]. Insomnia has been found to be a clinical predictor of subsequent depression \[[@B17-ijms-16-16514]\] and increased PSQI values are significantly associated with fatigue in MS patients \[[@B18-ijms-16-16514]\]. To date, evidence-based therapies of MS-related fatigue are lacking \[[@B19-ijms-16-16514],[@B20-ijms-16-16514]\], and patients without MS suffering from sleep disorders show equally high values on the fatigue scales (MFIS and FSS) \[[@B21-ijms-16-16514]\].

Sleep disorders can lead to fatigue \[[@B21-ijms-16-16514]\] and depression \[[@B16-ijms-16-16514]\] and CPAP therapy can subsequently improve these symptoms in patients with sleep apnea \[[@B15-ijms-16-16514],[@B22-ijms-16-16514]\]. This suggests that reduced HRQoL, fatigue and depression can be common features of sleep disorders. Due to the close and complex relationship between fatigue, depression and sleep disorders in MS, and the overlap of the used questionnaires \[[@B15-ijms-16-16514]\], we cannot state if sleep disorders lead to depression and subsequently to decreased HRQoL in the "*energy*" and "*emotional*" area---or *vice versa*, if sleep disorders lead to reduced daytime functioning and, subsequently, to depression.

Our findings underscore that sleep disorders should be considered an important confounder in all future studies investigating HRQoL in MS patients.

4. Experimental Section
=======================

4.1. Literature Search
----------------------

A literature search was performed until May 2015 in PubMed (<http://www.ncbi.nlm.nih.gov/pubmed>) with the following keywords: "multiple sclerosis AND Nottingham Health Profile" and "multiple sclerosis AND quality of life". After reading the abstracts, only relevant articles were read. Moreover, the references of these articles were read and hand-searched for potentially relevant studies or articles as well.

4.2. Patients
-------------

We classified the 66 patients (21 men and 45 women aged 20--66 years) into four subgroups: no sleep disorder (NSD) (*n* = 17), insomnia (*n* = 17), periodic limb movement disorder (PLMD), restless legs syndrome (RLS) or SD due to leg pain (PLMD/RLS) (*n* = 24), and untreated obstructive sleep apnea (OSA) (*n* = 8).

Expanded Disability Status Scale (EDSS) \[[@B12-ijms-16-16514]\] values ranged from zero to eight. For more demographic details please see the original article \[[@B1-ijms-16-16514]\]. All patients completed the NHP \[[@B10-ijms-16-16514]\], MFIS \[[@B13-ijms-16-16514]\], BDI \[[@B14-ijms-16-16514]\], and the PSQI \[[@B6-ijms-16-16514]\] in a German validation \[[@B23-ijms-16-16514],[@B24-ijms-16-16514],[@B25-ijms-16-16514],[@B26-ijms-16-16514]\].

The original study was approved by the local ethics committees (Charité University Medicine Berlin, Berlin, Germany and Ernst Moritz Arndt University Medicine, Greifwald, Germany, project identification code BB 03/08; 31 January 2008), and all participants gave written informed consent prior to the assessment.

4.3. Data Collection
--------------------

Data collection and extraction from the questionnaires (NHP) was performed by the corresponding author (CV). The PSG data extraction from the original study and the extraction of all questionnaires were performed by the corresponding author as well \[[@B1-ijms-16-16514]\].

4.4. Polysomnography and Scoring Criteria
-----------------------------------------

As described in our original article \[[@B1-ijms-16-16514]\], we performed PSG using a mobile polysomnographic device worn on the body, which has been validated in three different sleep centers \[[@B27-ijms-16-16514]\] (Somnocheck 2R&K, Weinmann Medical Technology; software: Somnolab; analysis software: Artisana, Hamburg, Germany) without a video or audio signal, but otherwise with full recording facilities as in a sleep laboratory.

Measurements were made over a period of 8 h: C3/C4-EEG electrodes to the contralateral mastoid electrode, ground electrode, electrooculogram on the ipsilateral mastoid electrode, bipolar chin electromyogram (EMG) of the muscle mentalis or muscle submentalis (according to biosignals testing and anatomical conditions), nasal airflow, thoracic breathing, abdominal breathing, position sensor, snoring signal, pulse oxymetry, pulse, electrocardiogram, bipolar 2-point EMG electrodes on both anterior tibial muscles. Prior to each measurement, an impedance test and a biosignal test were performed. A sleep specialist who was blinded to the clinical situation and the questionnaires analysed PSGs. Visual classification of sleep stages took place manually in accordance with Rechtschaffen and Kales \[[@B28-ijms-16-16514]\]. Respiratory events were manually classified using the diagnostic guidelines of the Task Force of the American Academy of Sleep Medicine \[[@B29-ijms-16-16514]\]. Periodic leg movements were pre-classified by the equipment's software and manually corrected using the Coleman criteria \[[@B30-ijms-16-16514]\]. We also investigated the hypnogram: sleep efficiency, sleep onset latency, sleep stages, wake-time after sleep onset, number of waking events, number of changes in sleep stages, arousal index, periodic leg movement (PLM) index, PLM index in rapid-eye-movement (REM) sleep and non-REM sleep, PLM arousal index in REM sleep and non-REM sleep, respiratory disturbance index (RDI), blood oxygen desaturation, as well as chin EMG tonus, all respiratory events depending on position, arousal and sleep stage, and further standard polysomnographic parameters. Due to the first-night effect (patient is not yet familiar with the polysomnographic device), no pathological findings were assessed from the first-night hypnogram. On the first night, only PLMs and respiratory and cardiac events were considered. Following classification of the PSGs, sleep histories were obtained (CV), and a sleep diagnosis was made according to the International Classification of Sleep Disorders second edition (ICSD-2) \[[@B31-ijms-16-16514]\]. To avoid false conclusions with respect to mild sleep disorders as possible causes of tiredness, mild insomnias, nocturia, mild PLMDs and sleep-related breathing disorders with RDI below 10 per hour were not considered relevant sleep disorders. We classified as relevant sleep disorders only sleep disorders with disturbed hypnogram, which are able to cause consecutive daytime sleepiness.

4.5. Statistical Analyses
-------------------------

The results were expressed as mean, standard deviation, and range. Patients were classified into four subgroups by the presence of a sleep disorder. Following an exploratory analysis of the data the non-parametric Kruskal--Wallis-Test and subsequently the Mann--Whitney-*U*-Test for pairwise comparisons were performed. Non-parametric correlations (Spearman--Rho) were carried out.

Statistical significance was established at *p* \< 0.05. Due to the exploratory nature of the study, all tests were performed as exploratory data analyses, such that no adjustments for multiple testing have been made. Analysis was performed with SPSS software (IBM^©^ SPSS^©^ Statistics, Version 21, ^©^Copyright 1989, 2010 SPSS Inc. an IBM Company, Chicago, IL, USA).

5. Conclusions
==============

Sleep disorders can decrease HRQoL in MS patients---especially in the "*energy*" and "*emotional*" areas. In OSA patients, the "*physical abilities*" area can be negatively impacted as well. Future studies should investigate the impact of the treatment of sleep disorders on HRQoL in MS patients.
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